New combo therapy could open door to liver transplants for more patients

This study looks at whether combining local treatments (like targeted radiation or chemo beads) with newer drugs (anti-VEGF/TKIs and immune checkpoint inhibitors) can shrink liver tumors enough for patients to qualify for a transplant. Researchers will review records of 300 patients, including about 100 who received this combo therapy. The goal is to see if this aggressive approach can safely turn ineligible patients into transplant candidates and improve their survival.